English | Spanish
ecancer
Login Register
The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Conferences
  • About us
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+ -
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [889]
News [2033]
Articles [110]
Editorials [8]
Conferences [70]
elearning [7]
New fluorophores could help fight cancer
New fluorophores could help fight cancer
New approach to treatment of deadly kidney cancer
New approach to treatment of deadly kidney cancer
Study shows why many cancer cells need to import fat
Study shows why many cancer cells need to import fat
Prostate cancer hijacks tumour cell biorhythm to evade hormone therapy
Prostate cancer hijacks tumour cell biorhythm to evade hormone therapy
Researchers identify cryptic vulnerabilities in an oncoprotein that could be used in the development of novel anti-cancer drugs
Researchers identify cryptic vulnerabilities in an oncoprotein that could be used in the development...
New biomarkers unlock potential for more effective treatment of deadly cancers
New biomarkers unlock potential for more effective treatment of deadly cancers
Cancer patients receiving immunotherapy: No evidence of increased risk for severe immune complication after COVID-19 vaccination
Cancer patients receiving immunotherapy: No evidence of increased risk for severe immune complicatio...
Olaparib in combination with abiraterone significantly improved rPFS versus abiraterone alone as a 1st-line treatment for patients with mCRPC
Olaparib in combination with abiraterone significantly improved rPFS versus abiraterone alone as a 1...
Scientists blend AI, 3D tissue imaging to identify aggressive prostate cancer
Scientists blend AI, 3D tissue imaging to identify aggressive prostate cancer
Researchers contribute to discovery of mechanism leading to drug resistance in prostate cancer
Researchers contribute to discovery of mechanism leading to drug resistance in prostate cancer
<12345...204>

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Follow ecancer on Facebook
  • Follow ecancer on Twitter
  • Follow ecancer on Linkedin
  • Subscribe to the ecancer YouTube channel
© 2022 ecancer, all rights reserved
UK registered charity number: 1176307